News for Roche Holding AG (0TDF.L)

Roche (RHHBY) announces the retirement of key executives, Dr. Hans Clevers and Barbara Schädler, scheduled for 2025. Dr. Hans Clevers will retire from

Roche Holding AG (OTCQX:RHHBY) Virtual Hematology Investor Conference Call June 23, 2025 1:00 PM ETCompany ParticipantsBruno Eschli - Head of Investor...

Key Insights: Genentech's trial yields a 59% reduction in disease progression for lymphoma patients. Analysts forecast a potential 14.78% upside for Roch

Roche (RHHBY) halts Elevidys dosing for non-ambulatory Duchenne muscular dystrophy patients due to safety concerns. Two fatal acute liver failure cases

ETFs tracking the performance of weight-loss drugs have largely underperformed since launching in late 2023.

Perrigo has announced that Matt Winterman will become the company's new Executive Vice President, Product Supply, Operations Strategy and Transformation Officer

PR NewswireDUBLIN, June 4, 2025 Ron Janish, EVP Global Operations and Supply Chain, to RetireIndustry Veteran, Matt Winterman, Appointed EVP Product Supply

Alphabet gains on AI-driven cloud, while YouTube and Google One push subscriptions past 270M despite litigation and cloud competition concerns.

Roche's Itovebi receives positive backing from the European Medicines Agency for breast cancer treatment. Analyst forecasts suggest a potential 12.76% upsid

Roche (RHHBY) secures FDA approval for Susvimo, enhancing its treatment portfolio for diabetic retinopathy. Analyst consensus suggests a "Hold" rating w

President Trump's executive order may impact Roche's $50 billion U.S. investment. Analysts suggest a potential upside of 18.25% for Roche's stock. Ro

Key Highlights: Roche (RHHBY) is set for substantial growth with a new $700 million facility. Analysts predict a 14.82% upside for Roche Holding AG's sto

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

Donald Trump’s executive order dismantling diversity, equity and inclusion efforts is making waves at international companies in Europe, Asia and beyond—but only on the surface. Quietly, many businesses are standing firm on diversity initiatives.  Companies from Roche Holding AG to Nissan Motor Co. have backpedaled on DEI policies in the…

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech Zealand Pharma's

Does Roche Holding AG (RHHBY) have what it takes to be a top stock pick for momentum investors? Let's find out.

A look at the largest and the best-performing large-cap global stock funds focusing on sustainability.

Market Analysis by covering: Novartis AG, Roche Holding AG Participation, NVIDIA Corporation, Johnson & Johnson. Read 's Market Analysis on Investing.com

Supply Lines is a daily newsletter that tracks global trade. . Switzerland said it’s one of 15 countries that will get “somewhat preferential treatment,”...